Clinical Trial Update: The Effects of Programmed Death-ligand 1 on Postoperative Pain for Lung Cancer Patients

View source ↗

Summary

This clinical trial, sponsored by Peking University People's Hospital, investigates the effects of PD-L1 modulation on postoperative pain in lung cancer patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Peking University People's Hospital | Conditions: Lung Cancer, Postoperative Pain | Status: RECRUITING